These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 382551)

  • 1. Bone grafting in inbred mice: evidence for H-2K, H-2D, and non-H-2 antigens in bone.
    Halloran PF; Lee E; Ziv I; Langer F
    Transplant Proc; 1979 Jun; 11(2):1507-9. PubMed ID: 382551
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthotopic bone transplantation in mice. II. Studies of the alloantibody response.
    Halloran PF; Lee EH; Ziv I; Langer F; Gross AE
    Transplantation; 1979 Jun; 27(6):420-6. PubMed ID: 380081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of circulating anti-H-2 antibody and cell-mediated precursors in successful DBA/2J-plus-(DBA/2J X C3H/HeJ)F1 parabiosed mice.
    Drell DW; Carlson GA; Wegmann TG
    J Immunol; 1979 Nov; 123(5):2319-27. PubMed ID: 385781
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement and antibody-mediated rejection of mouse skin allografts with anti-H-2K, H-2D, H-2L antibodies.
    Capel PJ; de Waal RM; Démant P; Koene RA
    Transplant Proc; 1981 Mar; 13(1 Pt 1):649-53. PubMed ID: 7268885
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence that active suppression contributes to the success of H-2-incompatible orthotopic corneal allografts in mice.
    Sonoda Y; Ksander B; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1374-6. PubMed ID: 8442147
    [No Abstract]   [Full Text] [Related]  

  • 9. Split tolerance to the MHC class I molecule H-2Dd in animals transgenic for its soluble analog.
    Hunziker RD; Lynch F; Shevach EM; Margulies DH
    Hum Immunol; 1997 Feb; 52(2):82-94. PubMed ID: 9077557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of marrow graft rejection in murine model systems.
    Dennert G; Knobloch C; Yankelevich B
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):12-7. PubMed ID: 3321640
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between H-2 and vaccinia virus-induced antigens on the surface of infected cells.
    Senik A; Neauport-Sautes C
    J Immunol; 1979 Apr; 122(4):1461-7. PubMed ID: 448095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental manipulations and marrow-derived factors which affect the outcome of bone marrow transplantation across the H-2 barrier in lethally irradiated mice.
    Pierpaoli W; Kellerhals R; Buehler A; Sache E
    J Clin Lab Immunol; 1985 Mar; 16(3):115-24. PubMed ID: 3897543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype.
    Steinmuller D; Tyler JD; David CS
    J Immunol; 1981 May; 126(5):1747-53. PubMed ID: 6452477
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between foreign H-2-like antigens on MCG4 sarcoma and the in vivo rejection of this tumor by syngeneic and semisyngeneic mice.
    García-Olivares E; Torres MD; Gutiérrez F; Osorio C
    Rev Esp Fisiol; 1982 Mar; 38(1):9-12. PubMed ID: 7100610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
    Tashiro-Yamaji J; Kubota T; Yoshida R
    Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic islet transplantation using H-2 incompatible multiple donors.
    Gotoh M; Maki T; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):957-9. PubMed ID: 3152648
    [No Abstract]   [Full Text] [Related]  

  • 19. Effector mechanism of H-Y and non-H-2 incompatible skin graft rejection in mice.
    Ichikawa T; Kawai M; Uenaka A; Yamamoto H; Gotoh M; Mondon M; Mori T; Shiku H; Nakayama E
    Transplant Proc; 1989 Feb; 21(1 Pt 1):156-7. PubMed ID: 2650099
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification of immune responsiveness to tumour grafts (enhancement or inhibition) induced in mice by allogeneic embryos.
    Vlachov K; Kinsky RG; Voisin GA
    Folia Biol (Praha); 1983; 29(6):419-23. PubMed ID: 6667745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.